World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
50274
World Ranking
8764
National Ranking
4521

Overview

Akshay S. Desai is primarily affiliated with Brigham and Women's Hospital in the United States. Their research activity is focused extensively within the field of Medicine, with a particular concentration in Cardiology and Cardiovascular Medicine, which accounts for 437 of their publications. Other significant subfields include Endocrinology, Diabetes and Metabolism; Surgery; Pulmonary and Respiratory Medicine; and Epidemiology.

The scientist's work covers several main topics connected to cardiovascular and metabolic health. These include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Treatment and Management, Cardiac pacing and defibrillation studies, Pancreatic function and diabetes, Potassium and Related Disorders, and Hormonal Regulation and Hypertension.

Desai has contributed to numerous research articles published in major scientific journals. Frequent publication venues include the Journal of the American College of Cardiology, Circulation, European Heart Journal, JACC Heart Failure, and the European Journal of Heart Failure. These journals represent significant platforms in cardiovascular research, indicating the primary audience and academic communities engaged with their work.

Recent publications authored or coauthored by Akshay S. Desai demonstrate ongoing involvement in clinical and translational cardiovascular research. Notable papers include:

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (2022), published in the New England Journal of Medicine
  • SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials (2022), published in The Lancet
  • Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes (2020), published in JAMA
  • Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial (2021), published in The Lancet
  • Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction (2020), published in Circulation

Collaboration is a significant aspect of Desai's research practice. Frequent co-authors include John J.V. McMurray, Scott D. Solomon, Pardeep S. Jhund, Brian Claggett, and Muthiah Vaduganathan. This network highlights multidisciplinary partnerships within cardiovascular and metabolic research communities.

Best Publications

  • Angiotensin-neprilysin inhibition versus enalapril in heart failure.

    John J. V. McMurray;Milton Packer;Akshay S. Desai;Jianjian Gong

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Spironolactone for Heart Failure with Preserved Ejection Fraction

    Bertram Pitt;Marc A. Pfeffer;Susan F. Assmann;Robin Boineau

  • Strategies for Multivessel Revascularization in Patients with Diabetes

    Michael E. Farkouh;Michael Domanski;Lynn A. Sleeper;Flora S. Siami

  • Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction

    Scott D. Solomon;John J.V. McMurray;Inder S. Anand;Junbo Ge

  • Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

    Hans-Henrik Parving;Hans-Henrik Parving;Barry M. Brenner;John J.V. McMurray;Dick de Zeeuw

  • Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

    Marc A. Pfeffer;Brian Claggett;Susan F. Assmann;Robin Boineau

  • Rehospitalization for Heart Failure: Predict or Prevent?

    Akshay S. Desai;Lynne W. Stevenson

  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

    Karen A. Hicks;Kenneth W. Mahaffey;Roxana Mehran;Steven E. Nissen

  • Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

    Milton Packer;John J. V. McMurray;Akshay S. Desai;Jianjian Gong

  • Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

    Karl Swedberg;James B. Young;Inder S. Anand;Sunfa Cheng

  • Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy. A meta-analysis of randomized controlled trials

    A.S. Desai;J.C. Fang;W.H. Maisel;K.L. Baughman

  • Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.

    Eri T. Kato;Michael G. Silverman;Ofri Mosenzon;Thomas A. Zelniker

  • Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

    Scott D. Solomon;Brian Claggett;Eldrin F. Lewis;Akshay Desai

  • Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin- converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

    John J. V. McMurray;Milton Packer;Akshay S. Desai;Jim Gong

  • Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial

    Barry Greenberg;Javed Butler;G Michael Felker;Piotr Ponikowski

  • Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

    Shannon M. Dunlay;Michael M. Givertz;David Aguilar;Larry A. Allen

  • Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction

    Viviany R Taqueti;Scott D Solomon;Amil M Shah;Akshay S Desai

  • Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients

    Akshay S. Desai;John J. V. McMurray;Milton Packer;Karl Swedberg

  • Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

    Mark C Petrie;Subodh Verma;Kieran F Docherty;Silvio E Inzucchi

Frequent Co-Authors

Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
John J.V. McMurray
John J.V. McMurray University of Glasgow
Brian Claggett
Brian Claggett Brigham and Women's Hospital
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Karl Swedberg
Karl Swedberg University of Gothenburg
Michael R. Zile
Michael R. Zile Medical University of South Carolina
Eldrin F. Lewis
Eldrin F. Lewis Stanford University
Inder S. Anand
Inder S. Anand University of Minnesota
Milton Packer
Milton Packer Baylor University Medical Center
Pardeep S. Jhund
Pardeep S. Jhund University of Glasgow

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a career in healthcare, the USA offers flexible online pathways that can expand your options beyond traditional medical degrees. If you're eager to join the workforce quickly, lpn online programs allow you to train as a Licensed Practical Nurse in less time, offering a direct entry into patient care.

Mental health care is also a rapidly growing field. The pmhnp online programs provide fast-track routes to becoming a Psychiatric Mental Health Nurse Practitioner, a role in high demand across the country.

For those interested in leadership or administration, pursuing a online master of health administration can prepare you for executive and managerial positions in hospitals, clinics, and health systems.

Cost is often a concern for graduate study. Fortunately, universities now offer some of the most affordable mha programs to help you advance your healthcare career without overwhelming debt.

Online healthcare degrees are designed for flexibility, allowing you to balance study with personal and professional commitments while opening doors to a variety of rewarding roles in the medical field.

Best Scientists Citing Akshay S. Desai

Trending Scientists

Recently Published Articles